nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
|
|
|
|
10 |
2 |
p. e117-e128 |
artikel |
2 |
2022 ASH annual meeting
|
Cookson, Emma |
|
|
10 |
2 |
p. e87-e88 |
artikel |
3 |
Bone granulomatous infiltrate associated with mogamulizumab in a patient with mycosis fungoides
|
Carrasquilla-Capilla, Ana |
|
|
10 |
2 |
p. e155 |
artikel |
4 |
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
|
Zhang, Mingming |
|
|
10 |
2 |
p. e107-e116 |
artikel |
5 |
GPRC5D-targeting chimeric antigen receptors: a new treatment for multiple myeloma?
|
Gagelmann, Nico |
|
|
10 |
2 |
p. e82-e83 |
artikel |
6 |
Impostors out!
|
Kerep, Ana Zelić |
|
|
10 |
2 |
p. e90 |
artikel |
7 |
Leukaemia cutis and pancreatic and renal enlargement in a neonate
|
Zhou, Lin |
|
|
10 |
2 |
p. e156 |
artikel |
8 |
On the basis of sex: outcomes in myelodysplastic syndromes
|
Hochman, Michael J |
|
|
10 |
2 |
p. e83-e85 |
artikel |
9 |
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials
|
Gupta, Sumit |
|
|
10 |
2 |
p. e129-e141 |
artikel |
10 |
Secondary haematological malignancies
|
The Lancet Haematology, |
|
|
10 |
2 |
p. e79 |
artikel |
11 |
Sickle cell disease care in Lebanon: resource-constrained and humanitarian crisis adaptations
|
Yazbek, Soha |
|
|
10 |
2 |
p. e91-e92 |
artikel |
12 |
Structural racism in clinical research limits its validity and applicability
|
Hamad, Nada |
|
|
10 |
2 |
p. e85-e86 |
artikel |
13 |
Susan Kahn—a long-term look at thrombosis
|
Kirby, Tony |
|
|
10 |
2 |
p. e89 |
artikel |
14 |
Treatment approaches for patients with TP53-mutated mantle cell lymphoma
|
Lew, Thomas E |
|
|
10 |
2 |
p. e142-e154 |
artikel |
15 |
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial
|
Yong, Kwee |
|
|
10 |
2 |
p. e93-e106 |
artikel |
16 |
Upfront autologous transplantation still improving outcomes in patients with multiple myeloma
|
Beksac, Meral |
|
|
10 |
2 |
p. e80-e82 |
artikel |